Cite

HARVARD Citation

    Vano, Y. et al. (2022). Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study. International journal of cancer. 151 (8), pp. 1335-1344. [Online]. 
  
Back to record